Rare diseases
Investigational molecules
Locations
Back to Germany1 786 clinical trials in Berlin, Germany across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis
GermanyStudy on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura
GermanyStudy on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis
GermanyStudy of Ifinatamab Deruxtecan for Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer
GermanyStudy of Lutetium (177Lu) Edotreotide compared to standard treatment in patients with aggressive Grade 2 and Grade 3 gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
GermanyStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
GermanyStudy on the Effectiveness and Safety of Iptacopan with Drug Combination for Adults with Active Lupus Nephritis Class III-IV, +/- V
GermanyStudy on Long-Term Safety of GSK1070806 for Patients with Moderate to Severe Atopic Dermatitis
GermanyStudy on Bimekizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis
GermanyStudy on Deucrictibant and Icatibant for Treating Hereditary Angioedema Attacks in Adolescents and Adults
GermanyStudy on the Effects of Etavopivat for Patients Aged 12-65 with Sickle Cell Disease
GermanyStudy on the Safety and Tolerability of Cariprazine for Treating Schizophrenia in Adolescents Aged 13-17
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, including studies of metastatic prostate cancer, colorectal cancer, and innovative approaches for breast cancer treatment.
Novel combination therapies and targeted treatments are being evaluated to improve patient outcomes across multiple cancer types.
Comprehensive vaccine development programs targeting various viral infections, including studies on respiratory syncytial virus, cytomegalovirus, and herpes zoster.
These trials aim to enhance immune response and provide long-term protection against serious viral infections.
Innovative treatments for various chronic conditions, including autoimmune dementia, hypertriglyceridemia, and studies in transplant medicine.
Research focuses on developing targeted therapies and improving treatment outcomes for long-term conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
